Back to ELVN
Avidity Partners Management LP → ELVN
Avidity Partners Management LP ELVN Position History
Enliven Therapeutics, Inc. • Healthcare
Quarters held
5
Latest value
$25.2M
Q3 2026
Peak value
$27.9M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $2.2M |
| Q1 2026 | $16.5M |
| Q1 2026 | $15.7M |
| Q2 2026 | $27.9M |
| Q3 2026 | $25.2M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $25.2M | 550.0K | — | — |
| Q2 2026 | $27.9M | 550.0K | — | — |
| Q1 2026 | $15.7M | 400.0K | — | — |
| Q1 2026 | $16.5M | 400.0K | — | — |
| Q4 2025 | $2.2M | 140.3K | — | — |
Other funds holding ELVN
$449.6M
$394.2M
$343.9M
$326.4M
$312M
$310.6M
$294.5M
$261.1M